Evusheld Prophylaxis Improves Social Interactions, Anxiety, Depression, Agoraphobia, and Quality of Life in Blood Cancer Patients

Evusheld is a combination injection of tixagevimab and cilgavimab and is indicated for the pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older. Its use has been advocated for immunosuppressed individuals, such as blood cancer patients, although uptake varies signif...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Annabel M. Follows, Charlotte Clark, Catherine Dye, Lorraine King, Gail Skillings, Grace Byrne, Vicki Tinkler, George A. Follows
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-04-01
Edice:	COVID
Témata:	COVID-19 Evusheld EQ5D-3L blood cancer
On-line přístup:	https://www.mdpi.com/2673-8112/3/5/48
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!